David Uprichard Insider Profile

4 Followers
David Uprichard, Director at Cyclacel Pharmaceuticals, holds 25.31K shares in Cyclacel Pharmaceuticals (Ticker: CYCC), holds ― shares in Life Technologies Corp (Ticker: ~LIFE). Most recently, David Uprichard ― shares of Cyclacel Pharmaceuticals on ― for an estimated value of ―.
tipranks
David Uprichard

David Uprichard
Cyclacel Pharmaceuticals (CYCC)
Director

Ranked #63,066 out of 78,624 Corporate Insiders

Profitable Transactions

23%
12 out of 52 Profitable Transactions

Average Return

-5.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$97K
100.00%
A breakdown of David Uprichard's holdings

Insider Roles

Cyclacel Pharmaceuticals
(CYCC)
Director
Roles that David Uprichard holds in companies

Most Profitable Insider Trade

Stock:
Life Technologies Corp
(~LIFE)
Rating:Informative Buy
Date:Feb 04, 2009 - Feb 04, 2010
Return:+31.50%
The most profitable trade made by David Uprichard

David Uprichard's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cyclacel Pharmaceuticals
Director
$97.43K
~LIFE
Life Technologies Corp
Feb 04, 2014
Uninformative Sell
223.06K
List of latest transactions for each holding click on a transaction to see David Uprichard's performance on stock

David Uprichard insider profile FAQ

What is the percentage of profitable transactions made by David Uprichard?
The percentage of profitable transactions made by David Uprichard is 23%.
    What is the average return per transaction made by David Uprichard?
    The average return per transaction made by David Uprichard is -5.50%.
      What stocks does David Uprichard hold?
      David Uprichard holds: CYCC, ~LIFE stocks.
        What was David Uprichard’s latest transaction?
        David Uprichard latest transaction was an Uninformative Buy of ―.
          What was David Uprichard's most profitable transaction?
          David Uprichard’s most profitable transaction was an Informative Buy of ~LIFE stock on February 4, 2009. The return on the trade was 31.50%.
            What is David Uprichard's role in Cyclacel Pharmaceuticals?
            David Uprichard's role in Cyclacel Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.